Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
19.89
-0.79 (-3.82%)
Nov 17, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 10.28 billion as of November 16, 2026. It is the 7,497th most valuable company in the world and the 1,430th biggest in China. Its market cap has increased by 8.54% in one year.
Market Cap
10.28B
Enterprise Value
8.37B
Revenue
1.56B
Global Rank
Country Rank
#1,430 China
PE Ratio
13,111.40
ChartMarket Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 10.28B, a decrease of -69.88%. That is a compound annual growth rate of -21.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 10.28B | 29.14% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 12.77B |
| BrightGene Bio-Medical Technology | 12.58B |
| Sino Biological,Inc. | 12.07B |
| Inner Mongolia Furui Medical Science | 11.47B |
| Chengdu Olymvax Biopharmaceuticals | 10.82B |
| Tibet Cheezheng Tibetan Medicine | 10.50B |
| Shanghai Medicilon | 10.16B |
| Novoprotein Scientific | 9.40B |